Yahoo · Sep 22, 2026
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.
IR
NASDAQ · IRTC
iRhythm Technologies, Inc
Healthcare · Medical - Devices
$111.05
Down-$2.61 (-2.30%)
Updated Oct 2, 2026, 6:33 AM
SID Score
4.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 5.45B
- P/E ratio
- -105.69
- Dividend yield
- 0.00%
- 52-week range
- $100.85 – $212.00
- Volume
- 373.98K
- Avg. volume
- 425.37K
Price performance · IRTC
IRTC price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
IRTC closed at $111.05 after 20 trading sessions, down 10.03% for the selected period.
- Last close
- $111.05
- Period change
- -10.03%
- Period low
- $109.33
- Period high
- $123.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $114.53 | $114.53 | $110.01 | $111.05 | 373.98K |
| Sep 30, 2026 | $114.51 | $114.75 | $112.19 | $113.66 | 339.82K |
| Sep 29, 2026 | $113.00 | $114.84 | $109.55 | $114.22 | 443.28K |
| Sep 28, 2026 | $110.38 | $112.9488 | $109.175 | $112.60 | 454.73K |
| Sep 25, 2026 | $110.74 | $111.46 | $108.975 | $110.38 | 521.92K |
| Sep 24, 2026 | $111.57 | $112.08 | $109.50 | $110.80 | 488.55K |
| Sep 23, 2026 | $111.01 | $117.03 | $111.005 | $111.75 | 1.23M |
| Sep 22, 2026 | $111.64 | $112.20 | $109.65 | $110.53 | 402.81K |
| Sep 21, 2026 | $109.22 | $111.38 | $107.915 | $110.38 | 385.08K |
| Sep 18, 2026 | $112.05 | $112.46 | $108.58 | $109.33 | 690.93K |
| Sep 17, 2026 | $112.47 | $113.445 | $111.19 | $111.75 | 365.44K |
| Sep 16, 2026 | $111.84 | $114.22 | $111.13 | $111.82 | 479.69K |
| Sep 15, 2026 | $113.79 | $115.16 | $110.81 | $111.88 | 452.26K |
| Sep 14, 2026 | $113.17 | $115.48 | $112.45 | $114.72 | 606.28K |
| Sep 11, 2026 | $114.82 | $116.01 | $110.20 | $111.43 | 524.57K |
| Sep 10, 2026 | $118.08 | $121.55 | $112.33 | $112.88 | 727.31K |
| Sep 9, 2026 | $121.19 | $124.91 | $119.03 | $119.57 | 978.83K |
| Sep 8, 2026 | $121.38 | $123.93 | $119.94 | $122.24 | 480.09K |
| Sep 4, 2026 | $121.47 | $123.52 | $120.565 | $123.07 | 444.54K |
| Sep 3, 2026 | $124.43 | $125.35 | $120.78 | $123.43 | 430.06K |
Latest IRTC news
The latest Smart Investors Daily articles mentioning IRTC.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IRTC research
Overview
Company profile and research snapshot.
Company profile
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $210.80
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 18, 2026 | Wells Fargo | Overweight | — |
| Aug 10, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Wells Fargo | Overweight | — |
| Aug 7, 2026 | Needham | Buy | — |
| Aug 7, 2026 | Evercore ISI Group | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 21, 2026
Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how patient monitoring stocks fared in Q2, starting with iRhythm (NASDAQ:IRTC).
Yahoo · Sep 4, 2026
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Yahoo · Sep 4, 2026
Smart Wearable ECG Monitors Market Size, Share & Trends Analysis, Global Forecast to 2036. Market Growth from $2.4B (2026) to $6.4B by 2036, Profiles Apple, AliveCor, iRhythm, Philips, and 12 Other Key Players
317-Page Report Maps Patch, Smartwatch, and Handheld ECG Devices as Regulatory Clearances and AI-Powered Arrhythmia Detection Reshape Cardiac Monitoring Outside the ClinicDublin, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The "Smart Wearable ECG Monitors Market Size, Share & Trends Analysis, - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. Market Size and Forecast The global smart wearable ECG monitors market is estimated to be valued at USD 2.4 billion in 2026 and is proj
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
